AU2001273501A1 - Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists - Google Patents

Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists

Info

Publication number
AU2001273501A1
AU2001273501A1 AU2001273501A AU7350101A AU2001273501A1 AU 2001273501 A1 AU2001273501 A1 AU 2001273501A1 AU 2001273501 A AU2001273501 A AU 2001273501A AU 7350101 A AU7350101 A AU 7350101A AU 2001273501 A1 AU2001273501 A1 AU 2001273501A1
Authority
AU
Australia
Prior art keywords
arylsulfoxides
arylsulfides
arylsulfones
beta
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273501A
Inventor
Patrick Michael Andrae
Dominick Anthony Quagliato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU2001273501A1 publication Critical patent/AU2001273501A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001273501A 2000-07-17 2001-07-16 Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists Abandoned AU2001273501A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21876300P 2000-07-17 2000-07-17
US60218763 2000-07-17
PCT/US2001/022348 WO2002006250A1 (en) 2000-07-17 2001-07-16 Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists

Publications (1)

Publication Number Publication Date
AU2001273501A1 true AU2001273501A1 (en) 2002-01-30

Family

ID=22816413

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273501A Abandoned AU2001273501A1 (en) 2000-07-17 2001-07-16 Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists

Country Status (3)

Country Link
US (1) US6458817B1 (en)
AU (1) AU2001273501A1 (en)
WO (1) WO2002006250A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465501B2 (en) 2000-07-17 2002-10-15 Wyeth Azolidines as β3 adrenergic receptor agonists
US6525202B2 (en) * 2000-07-17 2003-02-25 Wyeth Cyclic amine phenyl beta-3 adrenergic receptor agonists
US6537994B2 (en) 2000-07-17 2003-03-25 Wyeth Heterocyclic β3 adrenergic receptor agonists
US6410734B1 (en) * 2000-07-17 2002-06-25 Wyeth 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
US6498170B2 (en) 2000-07-17 2002-12-24 Wyeth Cyclamine sulfonamides as β-3 adrenergic receptor agonists
AU2002952839A0 (en) * 2002-11-21 2002-12-05 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3267406D1 (en) * 1981-07-11 1985-12-19 Beecham Group Plc Secondary phenyl ethanol amines and their pharmaceutical use
EP0089154A3 (en) 1982-03-12 1984-08-08 Beecham Group Plc Ethanolamine derivatives, their preparation and use in pharmaceutical compositions
EP0449261A3 (en) 1990-03-29 1992-02-26 Kabushiki Kaisha Toshiba Resin composition for an optical disc and an optical disc using it
US5776983A (en) 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
NO303782B1 (en) 1994-03-23 1998-08-31 Sankyo Co Thiazolidine and oxazolidine derivatives and pharmaceutical preparations containing them, as well as their use in the manufacture of medicaments
US5561142A (en) 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US5789402A (en) 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5614523A (en) 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA967892B (en) 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ATE239694T1 (en) 1995-10-26 2003-05-15 Mitsubishi Pharma Corp PHENYLETHANOLAMINE COMPOUNDS AND THEIR USE AS BETA3 AGONISTS, METHOD FOR THEIR PRODUCTION AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION
FR2780057B1 (en) 1998-06-18 2002-09-13 Sanofi Sa PHENOXYPROPANOLAMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2798126B1 (en) 1999-09-08 2001-10-19 Sanofi Synthelabo HETEROARYLOXYPROPANOLAMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2802533B1 (en) 1999-12-17 2002-02-15 Sanofi Synthelabo PHENOXYPROPANOLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
US6458817B1 (en) 2002-10-01
WO2002006250A1 (en) 2002-01-24
US20020040023A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2002222929A1 (en) Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
AU2002222932A1 (en) N-(4-sulfonylaryl)cyclylamine-2-hydroxyethylamines as beta-3 adrenergic receptor agonists
AU2001280568A1 (en) Heterocyclic beta-3 adrenergic receptor agonists
AU5203999A (en) Beta3-adrenergic receptor agonists
IL154911A0 (en) Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
AU2003288195A1 (en) Web service agent
AU2003243637A1 (en) Cannabinoid receptor agonists
AU2001243345A1 (en) 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
AU4217299A (en) Pth1r and pth3r receptors, methods and uses thereof
AU2002223501A1 (en) Glucagon antagonists/inverse agonists
AU2001273515A1 (en) Azolidines as beta-3 adrenergic receptor agonists
AU4729699A (en) Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
AU2002246498A1 (en) Functional balanced-lethal host-vector systems
AU2002223500A1 (en) Glucagon antagonists/inverse agonists
AU2001239774A1 (en) Antibacterial agents and compositions, methods and systems employing same
AU2001273508A1 (en) Heterocyclic beta-3 adrenergic receptor agonists
AU2001235773A1 (en) Electro-luminiscent polymers, their preparation and uses
AU2002210913A1 (en) Hydrogenated polymer
AU2001273542A1 (en) 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
AU2001276749A1 (en) Polymer composition
AU2001286409A1 (en) N-methyl-d-aspartate receptor antagonists
AU6594401A (en) 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
AU2001273501A1 (en) Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists
AU2001247227A1 (en) 2-thioether a2a receptor agonists
AU9275001A (en) Notch receptor agonists and uses